A Randomized Phase II Trial of mFOLFOX6+Bevacizumab Alone or with AdCEA Vaccine plus Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

Redman, JM; Tsai, YT; Weinberg, BA; Donahue, RN; Gandhy, S; Gatti-Mays, ME; Sater, HA; Bilusic, M; Cordes, LM; Steinberg, SM; Marte, JL; Jochems, C; Kim, SS; Marshall, JL; McMahon, S; Redmond, E; Schlom, J; Gulley, JL; Strauss, J

Redman, JM (通讯作者)，NCI, Canc Immunotherapy Program, Genitourinary Malignancies Branch, NIH, 10 Ctr Dr,Room 13N240, Bethesda, MD 20892 USA.;Redman, JM (通讯作者)，NCI, Lab Tumor Immunol & Biol, Med Oncol Serv, NIH, 10 Ctr Dr,Room 13N240, Bethesda, MD 20892 USA.

ONCOLOGIST, 2022; 27 (3): 198

Abstract

This article presents the findings of a randomized phase II clinical trial comparing FOLFOX-based standard of care to FOLFOX-based standard of care pl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索